... Monogram announces availability of HERmark and HER1 and HER3 Total Pr... Assays in Collaborative Biomarker Study ...SOUTH SAN FRANCISCO Calif. June 2 /- Monogram... HERmark is the first diagnostic built upon our VeraTag technology s...

Monogram announces availability of HERmark and HER1 and HER3 Total Protein

Assays in Collaborative Biomarker Study

SOUTH SAN FRANCISCO, Calif., June 2 /PRNewswire-FirstCall/ -- Monogram
Biosciences, Inc. (Nasdaq: MGRM) today announced that scientific
collaborators have presented additional clinical results on HERmark(TM),
the company's novel oncology assay, as a means to measure HER2 total
protein and homodimer levels and predict response to Herceptin(R)
(trastuzumab) in patients with metastatic breast cancer at the 44th ASCO
Annual Meeting taking place in Chicago, Illinois. Monogram also announced
the initiation of a Collaborative Biomarker Study involving the company's
HERmark Breast Cancer Assay and the HER1 and HER3 Total Protein Assays.

"HERmark is the first diagnostic built upon our VeraTag technology,"
said Monogram CEO Bill Young. "Today we are announcing two developments
that will elevate the profile of HERmark in the oncology community. First,
important clinical data presented today demonstrates the superiority of
HERmark over FISH testing for HER2. Second, we are initiating a study that
will provide an opportunity for participating oncologists to experience
first hand the superiority of HERmark in their clinical practices. We look
forward to completing our commercial planning and to a future commercial
launch of HERmark throughout the U.S."

HERmark Clinical Data

The oral presentation, entitled "Total HER2 and HER2 Homodimer Levels
Predict Response to trastuzumab," discussed the findings of a study that
investigated the HERmark assay's ability to identify and discriminate among
patients with metastatic breast cancer who experienced different degrees of
response to trastuzumab. The stu'/>"/>

(Date:7/30/2015)... , July 30, 2015 GenoSpace , ... the interpretation and analysis of genomic and other ... has joined the company as Vice President ... http://photos.prnewswire.com/prnh/20150730/250931 "GenoSpace partners ... integrate, interpret, analyze and explore complex sets of ...

(Date:7/30/2015)... Kan. , July 30, 2015 ... a pet therapeutics company focused on the licensing, ... companion animals, today announced that its strategic partner ... a dose confirmation study of AT-016, an adipose-derived ... for the treatment of osteoarthritis pain in dogs. ...

(Date:7/30/2015)... , July 30, 2015 Discovery Laboratories, Inc. ... has received the second $1.0M tranche under a ... (SBIR) grant valued at up to $3.0 million ... KL4 surfactant as a potential medical countermeasure to ... Labs was awarded an initial $1.0 million under ...

(Date:7/29/2015)... BANGALORE , July 30, 2015 ... Cell Market - Growth, Trends & Forecasts (2015-2020), , published ... worth US$ 30.25 billion by the end of 2020, with ... globally accounting for more than 40% of the global market ... grow at a CAGR of 13.7% during the period of ...

... Aug. 22 ZymoGenetics, Inc. (Nasdaq:,ZGEN) announced that ... to,provide an update on the regulatory review of ... be accessed on August 22 at 5:00,p.m. Eastern ... in to the call approximately 10 minutes prior ...

... Navy has awarded,Reed Group a contract to provide ... licenses for MDA for Windows. Based on The ... by Presley Reed, MD, MDA Internet and MDA ... and civilian employees of the,U.S. Navy. The ...

... in cosmetics and ... toiletries market -, LITTLE FALLS, N.J., Aug. ... of the importance of,better oral care appears to have paid off as ... a newly published study by global,management consulting and market research firm Kline ...

... Swiss researchers studying the projected effects of climate change ... may represent a ,safer, place to live during changing ... of Biogeography , finds that the habitat diversity of ... important for conservation. The research, led by ...

... - Researchers have created a new type of heart pump ... infants undergoing a series of surgeries to correct a deadly ... pump" for children born with univentricular circulation, a congenital heart ... defects in the first year of a child,s life, said ...

... Colo. (Nov. 9, 2010) As dog bites become an increasingly ... are most at risk for bites, that the culprits are usually ... with the second attack often more brutal than the first. ... Durairaj, MD, of the University of Colorado School of Medicine, who ...